BioSpace News Archive

In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the creation of the Ontario Drug and Dental Program and the expansion of OHIP + to seniors.

With Broward Health facing a growing demand for experienced nurses and top healthcare system managers, the Broward Health Board of Commissioners today took multiple steps to attract and retain top talent based upon fair market valuations.

PTC Therapeutics, Inc. announced the pricing of a public offering of 4,000,000 shares of its common stock at a public offering price of $27.04 per share, before underwriting discounts.

Kazia Therapeutics Limited is pleased to announce commencement of an international phase II clinical trial of its lead program, GDC-0084.

Centro de Imagem Diagnósticos SA announces its results for the fourth quarter of 2017 (4Q17).

The Public Health Agency of Canada is collaborating with provincial public health partners, the Canadian Food Inspection Agency and Health Canada to investigate an outbreak of Salmonella Enteritidis infections in four provinces with cases of human illness linked to poultry, including frozen raw breaded chicken products.

Regional Health Properties, Inc. announced postponing the release of its financial results for the fourth quarter and full-year period ended December 31, 2017 and its previously announced conference call to discuss such results originally scheduled for March 29, 2018.

Heron Therapeutics, Inc. announced the pricing of an underwritten public offering of 6 million shares of its common stock, offered at a price of $26.00 per share.

ProMetic Life Sciences Inc. reported its fourth quarter and year ended December 31, 2017 highlights and financial results.

Clinical benefits in both heart and liver observed in patients treated with PBI-4050 over an average of 52 weeks of treatment.